Compare ACRS & MCFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACRS | MCFT |
|---|---|---|
| Founded | 2012 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 311.0M | 329.0M |
| IPO Year | 2015 | 2015 |
| Metric | ACRS | MCFT |
|---|---|---|
| Price | $3.50 | $20.81 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 5 |
| Target Price | $9.75 | ★ $22.25 |
| AVG Volume (30 Days) | ★ 2.5M | 144.0K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 69.01 | N/A |
| EPS | N/A | ★ 0.38 |
| Revenue | $1,683,000.00 | ★ $284,203,000.00 |
| Revenue This Year | N/A | $9.18 |
| Revenue Next Year | $4.24 | $8.23 |
| P/E Ratio | ★ N/A | $56.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.05 | $14.42 |
| 52 Week High | $4.89 | $26.49 |
| Indicator | ACRS | MCFT |
|---|---|---|
| Relative Strength Index (RSI) | 50.91 | 48.10 |
| Support Level | $2.67 | $18.86 |
| Resistance Level | $3.86 | $21.20 |
| Average True Range (ATR) | 0.26 | 0.71 |
| MACD | -0.01 | 0.19 |
| Stochastic Oscillator | 46.32 | 62.69 |
Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two reportable segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing inventive therapies to address unmet needs for immuno-inflammatory diseases, and the contract research segment is engaged in providing laboratory services. A majority of the company's revenue is derived from the therapeutics segment. The various drug candidates in its product pipeline are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138, an ITJ Inhibitor; Bosakitug, ATI-052, and Lepzacitinib.
MasterCraft Boat Holdings Inc designs, manufactures, and markets performance sport boats and outboard boats. The company is based in the United States and operates in three brand-specific segments. The MasterCraft segment generates the majority of the company's revenue and includes inboard boats for water skiing, wakeboarding, and wake surfing. The Pontoon segment produces pontoon boats at its Owosso, Michigan facility. Pontoon boats are used for general recreational boating. The Aviara segment produces luxury day boats at its Merritt Island, Florida facility. Aviara boats are used for general recreational boating.